The TDP-43 protein, also known as TAR DNA-binding protein 43, is primarily known for its important roles in gene expression and neuronal plasticity in the brain.
In recent years, numerous studies have revealed a close link between TDP-43 and a variety of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration (FTLD), and limbic-predominant age-related TDP-43 encephalopathy (LATE).

Groundbreaking Study
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) in Spain, together with the Ludwig Maximilian University of Munich in Germany, led by Victor Arribas and Eloy Montanez, used genetically modified mice lacking TDP-43 in endothelial cells, the cells that make up the walls of blood vessels.

Significant Discoveries in the Retina
In a model of the developing mouse retina, the study found that these mice suffered from a range of significant defects in retinal blood vessels, including:

Hypovascularization: A significant decrease in retinal blood vessel density, preventing the supply of essential blood and oxygen to the tissue.
Impaired Sprouting of New Blood Vessels: Difficulty in forming new vascular networks, due to decreased proliferation and migration of endothelial cells, processes essential for the growth and maintenance of retinal tissue.

Significant Discoveries in the Brain and Central Nervous System
In the mature blood vessels of the brain and spinal cord, loss of TDP-43 led to additional defects:

Multiple Hemorrhages: The mice developed multiple hemorrhages in the brain and spinal cord.
Increased Blood-Brain Barrier Permeability: Damage to the blood-brain barrier, allowing unwanted cells and molecules to penetrate the brain, potentially causing inflammation and neuronal damage.
Vascular Degeneration: Impairment of blood vessel stability and function, leading to reduced blood flow and oxygen supply.

Far-Reaching Implications
These vascular defects were found to be closely linked to an inflammatory response in the central nervous system.
Microglial cells and astrocytes, the brain's immune cells, were overactivated, which could lead to the destruction of nerve cells and cognitive impairment.

Novel Mechanism of Action
The researchers investigated the molecular mechanism through which TDP-43 affects vascular function.
They discovered that TDP-43 deficiency impaired the structure and strength of the extracellular matrix, particularly the fibronectin network surrounding and supporting sprouting blood vessels.
Additionally, TDP-43 deficiency was found to reduce signaling of the β-catenin pathway in endothelial cells, a pathway involved in regulating blood vessel growth and development.

Connection to DNA
In addition to its roles in gene expression and neuronal plasticity, TDP-43 has been linked in separate studies to the regulation of genome stability.
These studies (e.g., Mitra et al., PNAS 2019) showed that TDP-43 binds to DNA and is involved in DNA damage repair, which were not examined in the current vascular study.
Impairment of these functions may contribute to the development of neurodegenerative diseases.

Future Implications and New Hope
The findings of this groundbreaking study highlight the importance of TDP-43 for vascular health in the nervous system.
TDP-43 impairment could lead to accelerated aging, cognitive decline, and neurodegenerative diseases.

Additional Roles of TDP-43:

Regulation of Nuclear Processes: Studies have found that TDP-43 is involved in regulating many processes in the cell nucleus, including:
- RNA processing
- RNA export from the nucleus
- RNA translation into protein
Regulation of RNA Splicing: TDP-43 has been found to regulate the splicing of messenger RNA (mRNA), a process crucial for determining which proteins are translated from the mRNA.
Influence on Gene Activity: Studies have shown that TDP-43 can influence gene activity by binding to regulatory regions in the genome.

Research Implications:
The findings of this groundbreaking study open a window to a new world of research and development in the field of treating neurodegenerative diseases. Many researchers worldwide continue to investigate the roles of TDP-43 and the role of blood vessels in the development of these diseases. We anticipate significant progress in the coming years in developing new and more effective treatments:

Drug Development: Developing drugs targeting TDP-43 could lead to improved vascular function in the nervous system, preventing the development of neurodegenerative diseases, and even improving the condition of patients already suffering from these diseases.
Gene Therapy: Gene therapy approaches could correct the genetic defect causing TDP-43 deficiency or replace the defective protein.
Treatments Targeting the Immune System: These treatments could focus on reducing inflammation in the brain, which contributes to the destruction of nerve cells.

References:
https://pubmed.ncbi.nlm.nih.gov/38300714/